{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:52:27Z","timestamp":1781718747989,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370844"],"award-info":[{"award-number":["82370844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028250","name":"Studio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022LZY028"],"award-info":[{"award-number":["ZR2022LZY028"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jconrel.2026.114778","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:30:17Z","timestamp":1772497817000},"page":"114778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanoassembly-mediated immunometabolic reprogramming of CD4+ T cells suppresses \u03b2-cell autoimmunity in type 1 diabetes"],"prefix":"10.1016","volume":"393","author":[{"given":"Xixi","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuotong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40164-025-00636-5","article-title":"Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential","volume":"14","author":"Tong","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114778_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006530","article-title":"Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection","volume":"13","author":"Sia","year":"2017","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114778_bb0025","first-page":"a041596","article-title":"Breakdown and repair of peripheral immune tolerance in type 1 diabetes, Cold Spring Harb","volume":"14","author":"Nepom","year":"2024","journal-title":"Perspect. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114778_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00125-024-06329-8","article-title":"Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function","volume":"68","author":"Brown","year":"2025","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114778_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08830185.2023.2274574","article-title":"Low-dose IL-2 therapy in autoimmune diseases: an update review","volume":"43","author":"Zhang","year":"2024","journal-title":"Int. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114778_bb0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114778_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107342","article-title":"From pre-clinical efficacy to promising clinical trials that delay type 1 diabetes","volume":"208","author":"Collier","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"23","key":"10.1016\/j.jconrel.2026.114778_bb0050","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"9789","key":"10.1016\/j.jconrel.2026.114778_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114778_bb0060","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00125-018-4638-7","article-title":"A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice","volume":"61","author":"Besancon","year":"2018","journal-title":"Diabetologia"},{"issue":"9911","key":"10.1016\/j.jconrel.2026.114778_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114778_bb0070","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMra1911109","article-title":"Tolerance in the age of immunotherapy","volume":"383","author":"Bluestone","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114778_bb0075","first-page":"580","article-title":"An obligate cell-intrinsic function for CD28 in Tregs","volume":"123","author":"Zhang","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114778_bb0085","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.1021\/acsami.1c22964","article-title":"Targeted polymeric nanoparticles based on Mangiferin for enhanced protection of pancreatic \u03b2-cells and type 1 diabetes mellitus efficacy","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114778_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.22203\/eCM.v050a02","article-title":"Nanocarrier-encapsulated SGLT-2 inhibitor (dapagliflozin) protects against diabetic cardiomyopathy by reducing myocardial fibrosis","volume":"50","author":"Li","year":"2025","journal-title":"Eur. Cell. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-017-02251-3","article-title":"Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114778_bb0100","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival","volume":"128","author":"Bahmani","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40035-022-00324-y","article-title":"ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein","volume":"11","author":"Bonvicini","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114778_bb0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2011.03.003","article-title":"Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice","volume":"37","author":"Kaminitz","year":"2011","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114778_bb0120","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1021\/jacs.4c13644","article-title":"A granzyme B-cleavable T cell-targeted bispecific cell vesicle connector for reversing new-onset type 1 diabetes","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0125","doi-asserted-by":"crossref","first-page":"2345019","DOI":"10.1080\/21505594.2024.2345019","article-title":"Co-immunization with DNA vaccines encoding yidR and IL-17 augments host immune response against Klebsiella pneumoniae infection in mouse model","volume":"15","author":"Lv","year":"2024","journal-title":"Virulence"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114778_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000164","article-title":"Nano and microparticle emerging strategies for treatment of autoimmune diseases: multiple sclerosis and type 1 diabetes","volume":"9","author":"Kwiatkowski","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Sch\u00f6ttler","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114778_bb0145","doi-asserted-by":"crossref","first-page":"15191","DOI":"10.1021\/acsnano.1c05713","article-title":"Density of conjugated antibody determines the extent of fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells","volume":"15","author":"Kappel","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40580-021-00274-7","article-title":"Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities","volume":"8","author":"Lee","year":"2021","journal-title":"Nano Converg."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114778_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159569","article-title":"Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation","volume":"134","author":"Joy","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114778_bb0170","doi-asserted-by":"crossref","first-page":"1356869","DOI":"10.3389\/fimmu.2024.1356869","article-title":"Th17\/Treg balance: the bloom and wane in the pathophysiology of sepsis","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"Suppl","key":"10.1016\/j.jconrel.2026.114778_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2005.09.009","article-title":"Type 1 diabetes genes and pathways shared by humans and NOD mice","volume":"25","author":"Wicker","year":"2005","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114778_bb0180","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1021\/acs.nanolett.1c01131","article-title":"Tetrahedral framework nucleic acids induce immune tolerance and prevent the onset of type 1 diabetes","volume":"21","author":"Gao","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-015-0757-4","article-title":"CDP7657, an anti-CD40L antibody lacking an fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study","volume":"17","author":"Shock","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114778_bb0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the \u2018high-hanging fruit\u2019","volume":"17","author":"Carter","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2133\/dmpk.DMPK-11-RG-091","article-title":"Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound","volume":"27","author":"Wempe","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114778_bb0200","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00125-013-2935-8","article-title":"Double deficiency in IL-17 and IFN-\u03b3 signalling significantly suppresses the development of diabetes in the NOD mouse","volume":"56","author":"Kuriya","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2026.114778_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2018.00233","article-title":"Engineered T regulatory type 1 cells for clinical application","volume":"9","author":"Gregori","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114778_bb0210","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/med.20152","article-title":"Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road,Med","volume":"29","author":"Shen","year":"2009","journal-title":"Res. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114778_bb0215","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nnano.2017.69","article-title":"Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy","volume":"12","author":"Yuan","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114778_bb0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.114778_bb0230","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fimmu.2019.01653","article-title":"Prolonged impairment of immunological memory after anti-CD20 treatment in Pediatric idiopathic nephrotic syndrome","volume":"10","author":"Colucci","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10020-024-00791-1","article-title":"Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes","volume":"30","author":"Zou","year":"2024","journal-title":"Mol. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114778_bb0240","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s12276-024-01286-z","article-title":"Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1\u03b1 pathway","volume":"56","author":"Kang","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"859","key":"10.1016\/j.jconrel.2026.114778_bb0245","doi-asserted-by":"crossref","first-page":"eadi8753","DOI":"10.1126\/scisignal.adi8753","article-title":"Reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells","volume":"17","author":"Rosenlehner","year":"2024","journal-title":"Sci. Signal."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114778_bb0250","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1002\/jcp.30883","article-title":"Conditional inactivation of the L-type amino acid transporter LAT1 in chondrocytes models idiopathic scoliosis in mice","volume":"237","author":"Iwahashi","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0255","doi-asserted-by":"crossref","first-page":"798S","DOI":"10.3945\/an.115.011221","article-title":"Leucine metabolism in T cell activation: mTOR signaling and beyond","volume":"7","author":"Ananieva","year":"2016","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.12845","article-title":"mTOR signaling at the crossroads of environmental signals and T-cell fate decisions","volume":"295","author":"Huang","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2026.114778_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108987","article-title":"SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damage","volume":"237","author":"Tian","year":"2022","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114778_bb0270","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1111\/all.15798","article-title":"JPH203, a LAT1 inhibitor, alleviates steroid-resistant murine airway inflammation mediated by Th17 cells","volume":"78","author":"Hayashi","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2026.114778_bb0275","article-title":"Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114778_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108817","article-title":"LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse","volume":"109","author":"Owada","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114778_bb0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2021.09.006","article-title":"L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy","volume":"148","author":"Hayashi","year":"2022","journal-title":"J. Pharmacol. Sci."},{"issue":"21","key":"10.1016\/j.jconrel.2026.114778_bb0290","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.3390\/molecules26216562","article-title":"Chemical approaches for studying the biology and pharmacology of membrane transporters: the histidine\/large amino acid transporter SLC7A5 as a benchmark","volume":"26","author":"Scalise","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114778_bb0295","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10637-020-00924-3","article-title":"First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors","volume":"38","author":"Okano","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114778_bb0300","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:00:39Z","timestamp":1781715639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592600180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"alternative-id":["S016836592600180X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114778","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoassembly-mediated immunometabolic reprogramming of CD4+ T cells suppresses \u03b2-cell autoimmunity in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114778"}}